The CancerConnect Leukemia Newsletter

TraceyS

Stay Current With Leukemia Treatment Advances & Connect with Others

CancerConnect publishes daily cancer news, original articles and "tips" on the management of Leukemia. These are available in our monthly Leukemia newsletter.

Stay Current - Connect With Other Leukemia Patients

Join The CancerConnect Community: Connect with others and receive regular updates

Sign up for the Leukemia Newsletter Here

Comments

Leukemia

FEATURED

COMMUNITY

Overview of Leukemias

Signs, symptoms, diagnosis and treatment of acute and chronic myeloid and lymphoid leukemias.

Cancer Connect

Vidaza® May Provide Alternative Treatment for Elderly Patients with AML

Vidaza® May Provide Alternative Treatment for Elderly Patients with AML.

Cancer Connect

Arzerra™ Treatment for Chronic Lymphocytic Leukemia

Arzerra™ effective for treatment of CLL - maintenance delays progression but does not improve survival.

Cancer Connect

Siverson

The Leukemia Community - Connect With Other Leukemia Patients

Connect with Others at Top Cancer Centers - Second Opinion Options...

TraceyS

Gemtuzumab Ozogamicin A Safe & Effective Option for Patients with Relapsed AML

Gemtuzumab Ozogamicin A Safe and Effective Treatment Option for Patients with Relapsed Acute Myeloid Leukemia

Cancer Connect

Ipsum sunt aliqua

Venclexta® for Acute Myeloid Leukemia

Venclexta® expands treatment options for AML - ASCO 2020 update in elderly AML patients confirms benefit.

Cancer Connect

Clolar™ Approved for Pediatric Acute Lymphoblastic Leukemia

Cancer Connect

Two Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML

Research suggests some patients with CML can safely discontinue TKI therapy - NCCN guidelines published.

MedMaven

Calquence Treatment Improves Survival in Chronic Lymphocytic Leukemia

ASH 2019 update report Calquence delays CLL progression compared to Gazyva + Chlorambucil

MedMaven

Brukinsa BTK Inhibitor for CLL/SLL

Brukinsa is a novel BTK inhibitor with encouraging anti-cancer activity in the management of CLL/SLL.

MedMaven